NIBIB R01, “Dose Reduction in Pediatric Molecular Imaging,” PI: G. Sgouros, 05/2017-02/2023, Total Award Amount: $2,677,814
NCI R01, “Dose-Response in Radionuclide Therapy,” PI: G. Sgouros, 07/2018-06/2023, Total Award Amount: $3,335,047
NCI R01, “Combination Radiopharmaceutical Therapy and External Beam Radiotherapy,” PI: G. Sgouros, 09/2020-06/2025, Total Award Amount: $2,815,939
NIH R01, “Hyperspectral Single Photon Imaging of Targeted Alpha-Emitters,” PI: Y. Du/E. Frey/LJ. Meng, 07/2021-03/2025, Total Award Amount: $2,319,931
NIH U01, “High Energy and Spatial Resolution Multi-Isotope SPECT Imaging of Targeted Alpha-Emitters and their Daughters,” PI: G. Sgouros/E. Frey/Y. Du/LJ. Meng, 09/2021-05/2026, Total Award Amount: $3,827,636
NCI (via Rapid LLC), “Treatment optimization by combined alpha-emitter (alphaRPT)//radiotherapy (XRT) dosimetry for prostate cancer patients,” PI: E. Frey, 09/2019- 09/2022, Total Award Amount: $495,369
CDMRP, “Targeting GPNMB in Renal Tumors in Tuberous Sclerosis Complex and Translocation Renal Cell Carcinoma,” PD: K. Asrani,07/2022-06/2025, Total Award Amount (including Indirect Costs): $982,500
NIH R01, “Management of Unresectable Solid Tumors in the Liver by Engineered alpha-particle Radiotherapy,” PD: S. Sofou, 04/2023-03/2027, Total Award Amount (including Indirect Costs): $2,750,497
CDMRP/DOD, “Alpha-particle Radionuclide Therapy for Effective Control of Advanced, Soft-Tissue Metastatic Prostate Cancer: Focus on Low Toxicities and Quality of Life,”PD: S. Sofou, 09/2022-08/2024, Total Award Amount (including Indirect Costs): $1,227,231
CDMRP/DOD, “Alpha-particle radionuclide therapy for effective control of established, soft-tissue breast cancer metastases,”PD: S. Sofou, 09/2022-08/2024,Total Award Amount (including Indirect Costs): $1,637,499
CDMRP/DOD, “Alpha-particle radiotherapy for metastatic breast cancer to the brain,”PD: S. Sofou, 09/2022-08/2024, Total Award Amount (including Indirect Costs): $736,785
NIBIB R01, “Dose Reduction in Pediatric Molecular Imaging,” PI: G. Sgouros, 09/2022-08/2027, Total Award Amount: $3,651,845
NIH R01, “Alpha-Emitter Therapy of Osteosarcoma,” PI: G. Sgouros/D. Kraitchman, 04/02023-03/2028, Total Award Amount: $3,974,821
NIH R21, “Exosome-mediated therapy for liver cancer,” PD/PI: Y. Fu, 04/02023-03/2028, Total Award Amount: $450,312
